| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89582-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-97326-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35036-1mg | |||
| Carrier-Free | NBP2-35036-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35149-10ug | |||
| Carrier-Free | NBP2-35149-1000ug | |||
| Carrier-Free | NBP2-35149-500ug | |||
![Immunohistochemistry-Paraffin: Aminopeptidase PILS/ARTS1 Antibody [NBP3-14539] - Aminopeptidase PILS/ARTS1 antibody IHC of human liver. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/Aminopeptidase PILS-ARTS1 Antibody-Immunohistochemistry-Paraffin-NBP3-14539-img0001.jpg "Immunohistochemistry-Paraffin: Aminopeptidase PILS/ARTS1 Antibody [NBP3-14539] - Aminopeptidase PILS/ARTS1 antibody IHC of human liver. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval.")
![Immunohistochemistry-Paraffin: VEGF 165 Antibody [NBP3-14566] - Human Liver: Formalin-Fixed, Paraffin-Embedded (FFPE)](http://images.novusbio.com/fullsize/VEGF 165 Antibody-Immunohistochemistry-Paraffin-NBP3-14566-img0001.jpg "Immunohistochemistry-Paraffin: VEGF 165 Antibody [NBP3-14566] - Human Liver: Formalin-Fixed, Paraffin-Embedded (FFPE)")
![Immunohistochemistry-Paraffin: TEM Antibody [NBP2-97326] - Immunochemical staining of human TEM in human kidney with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/TEM-Antibody-Immunohistochemistry-Paraffin-NBP2-97326-img0001.jpg "Immunohistochemistry-Paraffin: TEM Antibody [NBP2-97326] - Immunochemical staining of human TEM in human kidney with rabbit polyclonal antibody at 1:100 dilution, formalin-fixed paraffin embedded sections.")
![Western Blot: TBX20 Antibody [NBP2-86845] - Host: Rabbit. Target Name: TBX20. Sample Type: Fetal Liver lysates. Antibody Dilution: 1.0ug/ml](http://images.novusbio.com/fullsize/TBX20-Antibody-Western-Blot-NBP2-86845-img0001.jpg "Western Blot: TBX20 Antibody [NBP2-86845] - Host: Rabbit. Target Name: TBX20. Sample Type: Fetal Liver lysates. Antibody Dilution: 1.0ug/ml")
![Immunohistochemistry-Paraffin: Estrogen Receptor Antibody (S21-V) [NBP1-30153] - human of breast tumor tissue stained with Estrogen Receptor antibody shows strong positive nuclear immunostaining.](http://images.novusbio.com/fullsize/108721_1.jpg "Immunohistochemistry-Paraffin: Estrogen Receptor Antibody (S21-V) [NBP1-30153] - human of breast tumor tissue stained with Estrogen Receptor antibody shows strong positive nuclear immunostaining.")
![Chromatin Immunoprecipitation: KAT3B/p300 Antibody (1H11G2) [NBP2-59233] - ChIP was performed using HeLa cells, the antibody against p300 and optimized PCR primer sets for qPCR. ChIP was performed with a ChIP-seq kit, using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2, 5 and 10 ug per ChIP experiment was analysed. IgG (2 ug/IP) was used as negative IP control. Quantitative PCR was performed with primers for two genomic regions near the ANKRD32 and IRS2 genes, used as positive controls, and for the coding region of the inactive MYOD1 gene and an intergeic region on chromosome 11, used as negative controls. Figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).](http://images.novusbio.com/fullsize/KAT3B-p300-Antibody-1H11G2-Chromatin-Immunoprecipitation-NBP2-59233-img0001.jpg "Chromatin Immunoprecipitation: KAT3B/p300 Antibody (1H11G2) [NBP2-59233] - ChIP was performed using HeLa cells, the antibody against p300 and optimized PCR primer sets for qPCR. ChIP was performed with a ChIP-seq kit, using sheared chromatin from 4 million cells. A titration of the antibody consisting of 1, 2, 5 and 10 ug per ChIP experiment was analysed. IgG (2 ug/IP) was used as negative IP control. Quantitative PCR was performed with primers for two genomic regions near the ANKRD32 and IRS2 genes, used as positive controls, and for the coding region of the inactive MYOD1 gene and an intergeic region on chromosome 11, used as negative controls. Figure shows the recovery, expressed as a % of input (the relative amount of immunoprecipitated DNA compared to input DNA after qPCR analysis).")
![SDS-Page: Recombinant Human FGF-16 Protein [NBP2-61311]](http://images.novusbio.com/fullsize/Recombinant-Human-FGF-16-Protein-SDS-Page-NBP2-61311-img0002.jpg "SDS-Page: Recombinant Human FGF-16 Protein [NBP2-61311]")
![SDS-Page: Recombinant Human FGF-17 Protein [NBP2-61312]](http://images.novusbio.com/fullsize/Recombinant-Human-FGF-17-Protein-SDS-Page-NBP2-61312-img0002.jpg "SDS-Page: Recombinant Human FGF-17 Protein [NBP2-61312]")
![SDS-Page: Mouse FGF-9 Protein [NBP2-35036]](http://images.novusbio.com/fullsize/Mouse-FGF-9-Protein-SDS-Page-NBP2-35036-img0001.jpg "SDS-Page: Mouse FGF-9 Protein [NBP2-35036]")
![SDS-Page: Recombinant Human FGF acidic/FGF1 Protein [NBP2-61310]](http://images.novusbio.com/fullsize/Recombinant-Human-FGF-acidic-FGF1-Protein-SDS-Page-NBP2-61310-img0002.jpg "SDS-Page: Recombinant Human FGF acidic/FGF1 Protein [NBP2-61310]")